Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of two
medications--clonidine and methylphenidate--alone or in combination to treat attention
deficit hyperactivity disorder in children ages 4 through 6.
Phase:
Phase 2
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)